Anthony H. Kim - 24 Mar 2022 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Reporting relationship
Chief Financial Officer
Issuer ticker
MRKR
Reported as of
24 Mar 2022
Net transaction value
-$17,490
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Mar 2022, 21:03:28 UTC
Prior SEC filing
22 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Loiacono, Attorney-in-Fact

Key filing fact

Anthony H. Kim filed Form 4 for Marker Therapeutics, Inc. (MRKR) on 28 Mar 2022.

Key facts

  • This page summarizes Anthony H. Kim's Form 4 filing for Marker Therapeutics, Inc. (MRKR).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 28 Mar 2022, 21:03.

Change

  • Previous filing in this sequence was filed on 22 Feb 2022.
  • Current net transaction value: -$17,490.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRKR transaction

Common Stock

Award

Transaction value
$0
Shares
+150,512
Change %
Price
$0.000000
Shares after
150,512
Date
24 Mar 2022
Ownership
Direct
Footnotes
F1
MRKR transaction

Common Stock

Tax liability

Transaction value
$17,490
Shares
-36,076
Change %
-24%
Price
$0.4848
Shares after
114,436
Date
24 Mar 2022
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award.

Footnote F2

Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .